Home News

2018 First Half results presentation

Operating income, growth figures, profitability and how our products have behaved.

Thu, 26/07/2018 - 12:15 0 min
Download related document
No votes yet
 
Related
9M 2018 Results Press Release
0 min
06/11/2018
ROVI announces an agreement with Biogaran for the marketing of its enoxaparin...
0 min
20/09/2018
ROVI has commenced the marketing of its enoxaparin biosimilar in Spain
0 min
19/09/2018